GPAT4 and ovarian cancer: Furthermore, in comparison to the individual parameters (GPAT4 or SLC7A11 expression), a high co-expression level of GPAT4-SLC7A11 was identified as a more effective predictor of poor prognosis in ovarian cancer (Figure 4E,F).